Use of pharmacogenetics to optimize immunosuppressant therapy in kidney-transplanted patients

V Urzì Brancati, C Scarpignato, L Minutoli, G Pallio - Biomedicines, 2022 - mdpi.com
… In particular, genetic factors have been estimated to play a role in this variability because of
… on the tacrolimus dose required to reach the target exposure in kidney transplant recipients […

Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives

R Oberbauer, O Bestard, L Furian, U Maggiore… - Transplantation …, 2020 - Elsevier
factors potentially impacting tacrolimus metabolism, and represents a simple and inexpensive
tool that could be … , and assist in individualizing and optimizing tacrolimus therapy [7]. …

Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation

M Yu, M Liu, W Zhang, Y Ming - Current drug metabolism, 2018 - ingentaconnect.com
… , including ethnicity, age, gender, concomitant medication, hepatic and renal dysfunction,
and genetic factors such as CYP3A5, CYP3A4 and ABCB1 SNPs [12, 16, 124]. Among them, …

Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and …

X Chen, DD Wang, H Xu, ZP Li - Expert Review of Clinical …, 2020 - Taylor & Francis
… along with pharmacogenetics of tacrolimus in pediatric patients undergoing kidney
transplantation to identify factors that explain variability and determine dosage regimens. These …

Pharmacogenetics based dose prediction model for initial tacrolimus dosing in renal transplant recipients

L Srinivas, N Gracious, RR Nair - Frontiers in Pharmacology, 2021 - frontiersin.org
… 6th-day tacrolimus C 0 /D ratio with multiple factors, including … A dosing equation to calculate
the required tacrolimus dose/… have been made to optimize tacrolimus dosing based on the …

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

JT Tang, LM Andrews, T van Gelder… - Expert opinion on …, 2016 - Taylor & Francis
… The authors concluded that optimization of initial Tac dosing using CYP3A5 … the first
dosing algorithm using a combination of genetic information and clinical factors in adult kidney

Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives

AL Degraeve, S Moudio, V Haufroid… - Expert opinion on …, 2020 - Taylor & Francis
… In kidney transplantation, tacrolimus (TAC) is at the cornerstone … , physiologic but also genetic
factors. It was suggested that … fuel the state-of-the-art in regard to TAC therapy optimization

Dosage optimization based on population pharmacokinetic analysis of tacrolimus in Chinese patients with nephrotic syndrome

T Lu, X Zhu, S Xu, M Zhao, X Huang, Z Wang… - Pharmaceutical …, 2019 - Springer
… was to merge genetic and non-genetic factors of tacrolimusdosage regimen in Chinese
nephrotic syndrome patients. … with higher tacrolimus concentrations in liver or kidney transplant …

Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity

Y Bentata - Artificial organs, 2020 - Wiley Online Library
… AMT but without genetic factors having been clearly identified. Symptoms of acute … genetic
polymorphism as a biomarker in the use of tacrolimus might prevent drug toxicity and optimize

Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients

LM Andrews, YI Li, BCM De Winter, YY Shi… - Expert opinion on …, 2017 - Taylor & Francis
… disturbances, drug–drug interactions, genetic factors and importantly, non-adherence […
clinical benefit, concluding that optimizing the initial Tac dose based on CYP3A5 genotype …